$VMD

Frazier William sold $117K of VMD

Frazier William (Chief Medical Officer) sold 10,000 shares of VIEMED HEALTHCARE, INC. (VMD) at $11.72 ($0.12M total) on 2026-06-25.

Original reporting
SEC EDGAR · Frazier William
Published Jun 26, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:59 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VMD
Neutral
medium confidence
Mentioned
$VMD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VMDNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by the Chief Medical Officer.

02

Market read

Traders may monitor VMD for follow-on insider activity, but the disclosure alone does not change the company’s fundamentals.

03

What to watch

The filing does not disclose reasons for the sale, whether other insiders sold/bought, or any concurrent operational updates that would connect the transaction to fundamentals.

Relevance 4/10Novelty 4/10Timing: filed 2026-06-26, sale dated 2026-06-25

Background

The article is an SEC Form 4 insider transaction disclosure for VIEMED Healthcare, Inc. (VMD).

Company-level read

Ticker impact

$VMDNeutralMedium confidence
Context

Form 4 shows CMO Frazier William sold 10,000 shares of VIEMED Healthcare at $11.72 on 2026-06-25, totaling $117,200.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a primary-source Form 4, but it provides no new company performance, guidance, or deal information. Insider sales often have non-informational explanations, and the article lacks follow-on context.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity or tax-related, and the absence of a stated 10b5-1 plan does not necessarily imply negative information.

Key entities

  • VIEMED HEALTHCARE, INC.

    Subject of the Form 4 insider transaction disclosure.

  • Frazier William

    Chief Medical Officer who sold 10,000 shares.

  • SEC Form 4

    Primary-source insider transaction report filed 2026-06-26.

Related articles

$VMDMedAI 8/10

Viemed Healthcare Q2 Earnings Call Highlights

Viemed Healthcare (NASDAQ:VMD) reported Q2 updates on home respiratory and sleep therapies. Management cited improved ventilator patient growth and said PAP setups rose, with sleep patients up about 5% sequentially and 44% YoY. Equipment sales nearly doubled to $19M. Gross profit was $45M (57.7% margin). Full-year net revenue guidance raised to $314M-$320M and adjusted EBITDA to $64M-$68M.

$VMDHigh

VIEMED HEALTHCARE, INC. (VMD): Results of Operations and Financial Condition

VIEMED HEALTHCARE, INC. (VMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsrelease.htm EX-99.1 Document VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Lafayette, Louisiana (August 3, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based hea